NAFLD CRITERIA DIAGNOSIS Presence of hepatic steatosis on ultrasound of the upper abdomen, associated with alcohol consumption 140 g of ethanol/week for men and 70 g of ethanol/week for women, and in the absence of liver diseases such as B and C viruses, autoimmune, metabolic, and toxic ( 2 )
This is unlikely but important to know
550 In Phase II trials (KARDIA-1), zilebesiran reduced systolic blood pressure in all treated patients, with effects lasting 6 months, opening new possibilities for NADs use in treating hypertension and CVDs
La Oficina Federal para Seguridad en la Atencin Sanitaria (BASG) inform que los pacientes reportaron serios efectos secundarios, incluidos hipoglucemia (bajos niveles de glucosa) y convulsiones
GLP-1 Clarification: Products marketed as "GLP-1 patches" do not contain pharmaceutical GLP-1 receptor agonists such as semaglutide or tirzepatide
If you experience severe symptoms at this dose, it is important to discuss this with your clinician before any escalation